Packer Roger J, Gurney James G, Punyko Judy A, Donaldson Sarah S, Inskip Peter D, Stovall Marilyn, Yasui Yutaka, Mertens Ann C, Sklar Charles A, Nicholson H Stacy, Zeltzer Lonnie K, Neglia Joseph P, Robison Leslie L
Department of Neurology, Center for Neuroscience and Behavioral Medicine, Children's National Medical Center, Washington, DC, USA.
J Clin Oncol. 2003 Sep 1;21(17):3255-61. doi: 10.1200/JCO.2003.01.202.
To describe the neurologic and neurosensory deficits in children with brain tumors (BTs), compare incidence of these deficits with that of a sibling control group, and evaluate the factors associated with the development of these deficits.
Detailed questionnaires were completed on 1,607 patients diagnosed between 1970 and 1986 with a primary CNS tumor. Neurosensory and neurologic dysfunctions were assessed and results compared with those of a sibling control group. Medical records on all patients were abstracted, including radiotherapy dose and volume.
Seventeen percent of patients developed neurosensory impairment. Relative to the sibling comparison group, patients surviving BTs were at elevated risk for hearing impairments (relative risk [RR], 17.3; P = <.0001), legal blindness in one or both eyes (RR, 14.8; P = <.0001), cataracts (RR, 11.9; P = <.0001), and double vision (RR, 8.8; P = <.0001). Radiation exposure greater than 50 Gy to the posterior fossa was associated with a higher likelihood of developing any hearing impairment. Coordination and motor control problems were reported in 49% and 26%, respectively, of survivors. Children receiving at least 50 Gy to the frontal brain regions had a moderately elevated risk for motor problems (RR, 2.0; P <.05). Seizure disorders were reported in 25% of patients, including 6.5% who had a late first occurrence. Radiation dose of 30 Gy or more to any cortical segment of the brain was associated with a two-fold elevated risk for a late seizure disorder.
Children surviving BTs are at significant risk for both early and late neurologic or neurosensory sequelae. These sequelae need to be prospectively monitored.
描述脑肿瘤(BT)患儿的神经和神经感觉缺陷,将这些缺陷的发生率与同胞对照组进行比较,并评估与这些缺陷发生相关的因素。
对1970年至1986年间诊断为原发性中枢神经系统肿瘤的1607例患者完成了详细问卷。评估神经感觉和神经功能障碍,并将结果与同胞对照组进行比较。提取了所有患者的病历,包括放疗剂量和体积。
17%的患者出现神经感觉损害。与同胞对照组相比,BT存活患者出现听力损害的风险升高(相对风险[RR],17.3;P =<.0001),单眼或双眼法定失明(RR,14.8;P =<.0001),白内障(RR,11.9;P =<.0001),以及复视(RR,8.8;P =<.0001)。后颅窝接受大于50 Gy的辐射与发生任何听力损害的可能性更高相关。分别有49%和26%的幸存者报告有协调和运动控制问题。额叶脑区接受至少50 Gy辐射的儿童出现运动问题的风险中度升高(RR,2.0;P<.05)。25%的患者报告有癫痫发作障碍,其中6.5%为首次发作较晚。大脑任何皮质节段接受30 Gy或更高剂量的辐射与晚期癫痫发作障碍的风险升高两倍相关。
BT存活儿童有发生早期和晚期神经或神经感觉后遗症的重大风险。这些后遗症需要进行前瞻性监测。